These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30084119)

  • 1. Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients.
    Choi SY; Viswanathan P; Sherwat A; Seo SK
    Clin Pharmacol Ther; 2018 Nov; 104(5):785-787. PubMed ID: 30084119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open-Label, Randomized Study.
    Adkison K; Wolstenholme A; Lou Y; Zhang Z; Eld A; Perger T; Vangerow H; Hayward K; Shaefer M; McCoig C
    Clin Pharmacol Ther; 2018 Mar; 103(3):402-408. PubMed ID: 29150845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Reyar S; Tiwari HK; Tippabhotla SK; Khuroo A; Thudi NR; Ahmed S; Raghuvanshi R
    Arzneimittelforschung; 2009; 59(2):104-8. PubMed ID: 19338141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
    Musiime V; Kendall L; Bakeera-Kitaka S; Snowden WB; Odongo F; Thomason M; Musoke P; Adkison K; Burger D; Mugyenyi P; Kekitiinwa A; Gibb DM; Walker AS;
    Antivir Ther; 2010; 15(8):1115-24. PubMed ID: 21149918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection.
    Casado JL; Bañón S
    Expert Rev Clin Pharmacol; 2015; 8(6):709-18. PubMed ID: 26517111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients.
    Bouazza N; Tréluyer JM; Msellati P; Van de Perre P; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Hirt D; Urien S
    AIDS; 2013 Mar; 27(5):761-8. PubMed ID: 23719348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations.
    Mukherjee A; Singla M; Velpandian T; Sirohiwal A; Vajpayee M; Singh R; Kabra SK; Lodha R
    Indian Pediatr; 2014 Mar; 51(3):191-7. PubMed ID: 24736906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of lamivudine.
    Johnson MA; Moore KH; Yuen GJ; Bye A; Pakes GE
    Clin Pharmacokinet; 1999 Jan; 36(1):41-66. PubMed ID: 9989342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
    Chokephaibulkit K; Plipat N; Cressey TR; Frederix K; Phongsamart W; Capparelli E; Kolladarungkri T; Vanprapar N
    AIDS; 2005 Sep; 19(14):1495-9. PubMed ID: 16135903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV.
    Bruno R; Regazzi MB; Ciappina V; Villani P; Sacchi P; Montagna M; Panebianco R; Filice G
    Clin Pharmacokinet; 2001; 40(9):695-700. PubMed ID: 11605717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs--reports of new drugs recently approved by the FDA. Lamivudine.
    Ohta Y; Shinkai I
    Bioorg Med Chem; 1997 Apr; 5(4):639-40. PubMed ID: 9158860
    [No Abstract]   [Full Text] [Related]  

  • 14. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
    Tremoulet AH; Capparelli EV; Patel P; Acosta EP; Luzuriaga K; Bryson Y; Wara D; Zorrilla C; Holland D; Mirochnick M;
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4297-302. PubMed ID: 17893155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic toxicity effects of lamivudine and stavudine antiretroviral agents.
    Guimarães NN; de Andrade HH; Lehmann M; Dihl RR; Cunha KS
    Expert Opin Drug Saf; 2010 Sep; 9(5):771-81. PubMed ID: 20377473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations.
    Bouazza N; Foissac F; Fauchet F; Burger D; Kiechel JR; Treluyer JM; Capparelli EV; Lallemant M; Urien S
    Antivir Ther; 2015; 20(2):225-33. PubMed ID: 25279808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine/zidovudine/abacavir: triple combination tablet.
    Ibbotson T; Perry CM
    Drugs; 2003; 63(11):1089-98; discussion 1099-1100. PubMed ID: 12749741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.
    Vourvahis M; Davis J; Langdon G; Layton G; Fang J; Choo HW; Hansson AG; Tawadrous M
    Antivir Ther; 2013; 18(6):745-54. PubMed ID: 23558061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. College students' knowledge and consumption of sorbitol.
    Oberrieder HK; Fryer EB
    J Am Diet Assoc; 1991 Jun; 91(6):715-7. PubMed ID: 2040789
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosage of lamivudine in a haemodialysis patient.
    Izzedine H; Launay-Vacher V; Deray G
    Nephron; 2000 Dec; 86(4):553. PubMed ID: 11124630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.